Rong-Zong Liu
Overview
Explore the profile of Rong-Zong Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
644
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu R, Garg M, Yang X, Godbout R
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273616
Chemotherapy is an important treatment option for advanced prostate cancer, especially for metastatic prostate cancer (PCa). Resistance to first-line chemotherapeutic drugs such as docetaxel often accompanies prostate cancer progression. Attempts...
2.
Choi W, Liu R, Mak C, Maadi H, Godbout R
FEBS J
. 2024 May;
291(15):3521-3538.
PMID: 38708519
HER2-enriched (HER2) breast cancers express high levels of the growth-promoting HER2 protein. Although these cancers are treated with the HER2-targeted drug, trastuzumab, resistance to treatment is common. Retinoic acid (RA)...
3.
Liu R, Choi W, Godbout R
Neuro Oncol
. 2024 Jan;
26(3):590-591.
PMID: 38244229
No abstract available.
4.
Liu R, Choi W, Jain S, Xu X, Elsherbiny M, Glubrecht D, et al.
Neuro Oncol
. 2023 Jul;
25(12):2177-2190.
PMID: 37499046
Background: Glioblastoma (GBM) stem-like cells (GSCs) are crucial drivers of treatment resistance and tumor recurrence. While the concept of "migrating" cancer stem cells was proposed a decade ago, the roles...
5.
Zhou J, Kong Y, Vincent K, Dieters-Castator D, Bukhari A, Glubrecht D, et al.
Mol Oncol
. 2023 Apr;
17(9):1763-1783.
PMID: 37057706
Glioblastoma (GBM) is the most common and aggressive malignant primary brain tumor in adults. The standard treatment achieves a median overall survival for GBM patients of only 15 months. Hence,...
6.
Liu R, Godbout R
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33352874
Treatment for early stage and localized prostate cancer (PCa) is highly effective. Patient survival, however, drops dramatically upon metastasis due to drug resistance and cancer recurrence. The molecular mechanisms underlying...
7.
Bharadwaj A, Dahn M, Liu R, Colp P, Thomas L, Holloway R, et al.
Cancers (Basel)
. 2020 Dec;
12(12).
PMID: 33297495
S100A10 (p11) is a plasminogen receptor that regulates cellular plasmin generation by cancer cells. In the current study, we used the MMTV-PyMT mouse breast cancer model, patient tumor microarray, and...
8.
Liu R, Choi W, Jain S, Dinakaran D, Xu X, Han W, et al.
Mol Oncol
. 2020 Oct;
14(12):3100-3120.
PMID: 33031638
Early stage localized prostate cancer (PCa) has an excellent prognosis; however, patient survival drops dramatically when PCa metastasizes. The molecular mechanisms underlying PCa metastasis are complex and remain unclear. Here,...
9.
Liu R, Vo T, Jain S, Choi W, Garcia E, Monckton E, et al.
J Pathol
. 2018 Oct;
247(2):186-198.
PMID: 30350349
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited treatment options and poor prognosis. There is an urgent need to identify and understand the key factors and...
10.
Liu R, Li S, Garcia E, Glubrecht D, Poon H, Easaw J, et al.
Glia
. 2016 Feb;
64(6):963-76.
PMID: 26893190
Retinoic acid (RA), a metabolite of vitamin A, is required for the regulation of growth and development. Aberrant expression of molecules involved in RA signaling has been reported in various...